Loading...
WATT is not a good buy right now. The setup is extended/overbought near resistance (RSI~84, price above R1), Intellectia signals show no fresh edge, and the latest quarter shows revenue growth off a small base but worsening profitability and margin pressure. For an impatient buyer, the risk/reward at this level is unfavorable versus waiting for a pullback or a new breakout with confirmation.
Trend/price action: Momentum is currently bullish but stretched. Price (7.989) is above Pivot (6.642) and slightly above R1 (7.805), moving toward R2 (8.524), which makes upside more limited near-term versus downside if momentum cools. Indicators: MACD histogram is positive and expanding (bullish momentum), but RSI(6) at ~83.65 signals overbought conditions where pullbacks are common. Moving averages are converging, suggesting the trend may be transitioning rather than in a clean, low-risk continuation. Levels: Support: 6.642 (pivot) then 5.479 (S1). Resistance: 8.524 (R2). A failed push toward/through 8.524 would increase odds of a mean-reversion dip. Quant-style pattern read: Similar-pattern study implies ~90% chance of about -1.2% next day, then +2.47% next week and +5.1% next month—near-term chop/pullback risk despite a potentially positive multi-week bias.
Intellectia Proprietary Trading Signals
Post-market uptick (+1.14%) and bullish MACD expansion indicate buyers are still active.
Multi-week pattern probability skew points to potential upside over the next month (+5.1%) if momentum holds.
Revenue in 2025/Q3 rose sharply YoY (albeit from a low base), which can support speculative interest.
with price sitting near/above a key resistance band (R1 to R2), increasing the odds of a near-term pullback—especially for an impatient entry.
Latest quarter: 2025/Q3. Revenue increased to $1.272M (+453.04% YoY), but profitability and efficiency weakened: Net income fell to -$2.113M (more negative, -38.07% YoY), EPS fell to -1.31 (-91.26% YoY), and gross margin dropped to 36.01 (down sharply YoY). Overall: strong top-line rebound off a small base, but worsening losses and margin pressure dominate the quality of growth.
No analyst rating/price target change data was provided, so there is no observable recent trend in upgrades/downgrades or target revisions to confirm Wall Street conviction. With no visible pro-side analyst support in the dataset, the balance of the provided evidence leans against chasing the current overbought move.
